1. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
   Masaaki Ito et al, 2023, Medicine International CrossRef
2. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma
   Masaaki Ito et al, 2024, Cancer Science CrossRef
3. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
   Liubing Hu et al, 2022, Frontiers in Oncology CrossRef
4. Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review)
   Amber Xinyu Li et al, 2023, Cancers CrossRef
5. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
   Masaaki Ito et al, 2022, Esophagus CrossRef
6. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
   Shu-Yang Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
7. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
   Bo-Shi Zhang et al, 2024, International Journal of Molecular Sciences CrossRef